| Name |
Creator |
 Specific Clinical Trials
|
|
Advances in Treatment Options for Metastatic Colorectal Cancer
Nov 2002 "Healthtalk" interview, Dr. Edward Lin (MD Anderson) and Dr Alan Venook (UCSF). Oxaliplatin, Xeloda/Celebrex, targeted therapies. Patient story - advanced unresectable liver metastases successfully "downstaged" by Xeloda/Celebrex
http://www.healthtalk.com/coloncancer/111902/index.html |
altman23
|
Are Large Clinical Trials Ethical?
In the February 22 issue of the Lancet, distinguished scientist Dr. David F. Horrobin argues that enrolling cancer patients in large clinical trials is generally unethical. Dr. Horrobin has been involved in biomedical research for many decades. He has medical and doctorate degrees from Oxford University and has taught at the Universities of Oxford, London, Nairobi, Newcastle, and Montreal. He edits two biomedical journals, "Medical Hypotheses" and "Prostaglandins, Leukotrienes, and Essential Fatty Acids," and is the author or co-author of 500 papers. He founded the biotech company, Scotia Holdings PLC, in 1979, and is currently Executive Chairman of Laxdale Ltd., a company that specializes in the development of new drugs for psychiatric and neurological disorders
http://www.cancerdecisions.com/030703.html |
altman23
|
Choices in Healing
Michael Lerner's father was diagnosed with lung cancer, and he explored many issues surrounding conventional, experimental and alternative therapies.
http://www.commonweal.org/choicescontents.html |
altman23
|
Colon Cancer Treatment: Making the Right Choices
Transcript of discussion with oncologists. "Being diagnosed with colon cancer is hard news to receive. Deciding how to treat it can be even more challenging. Do you know all your choices? How do you know which is best for you? Who will help you make the right treatment decisions? Join our panel as they discuss the available options--from diagnosis to treatment--and walk you through some possible scenarios"
http://www.healthology.com/webcast_transcript.asp?f=colon_cancer&c=colon_treatdecision&spg=FIP |
altman23
|
Dying Medicine Boss: 'Drug Trials Are Pointless And Unethical'
For the past 40 years Professor David Horrobin has been developing new medicines. In 1977 he founded Scotia Holdings, which was once one of Scotland's most promising biotechnology firms. But today, as the drug company boss is dying of cancer, he has decided to expose the unethical experiments that his industry carries out on patients
http://www.lef.org/news/disease/2003/03/02/SHLD/0000-3069-KEYWORD.Missing.html |
altman23
|
Glaxo chief: Our drugs do not work on most patients
A senior executive with Britain's biggest drugs company has admitted that most prescription medicines do not work on most people who take them.
http://news.independent.co.uk/world/science_medical/story.jsp?story=471139 |
altman23
|
Latest Advances in Colon Cancer
Transcript of discussion with oncologists. Screening for colon cancer, early stages of colon cancer, colon cancer prevention. "Join our panel of esteemed cancer experts as they report the latest information about colon cancer live from Atlanta, GA, the site of the May 1999 American Society of Clinical Oncology meeting. This medical conference is the largest gathering of cancer professionals of the year and some of the most advances in cancer are presented here."
http://www.healthology.com/webcast_transcript.asp?f=colon_cancer&c=latest_advances&spg=FIP |
altman23
|
Life Inside a Cancer Trial
Eight part series from "The Tennessian" (newspaper) - real life case histories from Vanderbilt Cancer Center
http://www.tennessean.com/special/cancer/archives/01/08/07624817.shtml |
altman23
|
Making Cancer Treatment Decisions
http://www.healthology.com/focus_article.asp?f=colon_cancer&c=making_decions |
altman23
|
Making Treatment Choices
Guidelines for making decisions from Arlene Harder's Learning Place Online
http://www.learningplaceonline.com/illness/choices-intro.htm |
altman23
|
Memory Problems Following Chemotherapy
Jan. 14, 2002 -- Evidence has been building that cancer chemotherapy can impair memory for at least a few years after treatment. Now, a new study shows that this effect can linger as long as 10 years.
http://my.webmd.com/content/article/16/2946_917 |
altman23
|
Modern Medicine: The New World Religion
Centuries after the conquistadors tried to stamp out the Inca culture, or the Inquisition tried to stamp out the protestant ‘heresies’, or the similar attempts to annihilate the Voodoo, or the many African and Asian religions, we know that such arrogant high-handedness does not work. These beliefs still continue today, sometimes under different guises, long after the objects of worship associated with them have been destroyed
http://www.sickofdoctors.addr.com/articles/modernmedicine.htm |
altman23
|
NCI Clinical Trial Search
http://www.nci.nih.gov/search/clinical_trials/ |
altman23
|
New Treatment Strategies for Colorectal Cancer
Transcript of discussion with oncologists. More on "downstaging" inoperable disease and neo-adjuvant (presurgical) use of chemo. Sphincter preservation surgery for rectal cancer patients. Complications of surgery. "Colorectal cancer is already a highly curable disease, and every new development in its treatment makes it more so. Join our panel -- which will include a gastroenterologist, an oncologist, and a surgeon -- as they discuss the latest in chemotherapy, radiation therapy, and surgery."
http://www.healthology.com/webcast_transcript.asp?f=colon_cancer&c=treatmentlive&spg=FIP |
altman23
|
Patients And Physicians Often Disagree On The Goal Of Chemotherapy
Cancer patients are more likely to expect that a cure is the goal of chemotherapy, while physicians are more likely to consider palliation to be the goal of chemotherapy, according to the results of a new survey presented at the annual meeting of the American Society of Clinical Oncology. Overall, the investigators found that patients and physicians agreed on the goal of chemotherapy less than half of the time.
http://www.cancerpage.com/cancernews/cancernews2779.htm |
altman23
|
Questioning Chemotherapy
Some passages from Ralph Moss' book
http://pub18.ezboard.com/fhavetheologywillarguecityofgodvssecularcity.showMessage?topicID=158.topic |
altman23
|
Questions to ask before signing up for a clinical trial
(from cancerlynx.com)
http://www.cancerlynx.com/questions.html |
altman23
|
Quiet Celebrity: Interview with Judah Folkman
Scientific American Article, 11/4/02. Why clinical trials don't work. "With humans, of course, the rules are strict: you can only give a single drug to patients with very advanced tumors, starting at very low doses. For example, we found the most dramatic effects in mice when endostatin and angiostatin were used in combination, but the FDA will not allow to use both drugs together before the end of phase II, maybe early phase III [large-scale, with many human patients] of the trials. Moreover, we have evidence that the drugs would work better if given at an early stage of the tumor"
http://www.sciam.com/article.cfm?chanID=sa004&articleID=00077C61-DE6E-1DC2-AF71809EC588EEDF&pageNumber=2&catID=4 |
altman23
|
Steve Dunn's Cancerguide
One of the best sites I have seen covering clinical trials, how to do your own cancer research, etc.
http://www.cancerguide.org/mainmenu.html |
altman23
|
The Chemotherapy Concession
NY Times, January 26, 2003 Among cancer doctors, it is called the chemotherapy concession. At a time when overall spending on prescription drugs is soaring, cancer specialists are pocketing hundreds of millions of dollars each year by selling drugs to patients — a practice that almost no other doctors follow.
http://www.globalaging.org/health/us/ds.htm |
altman23
|
The Efficacy of Chemotherapy for Cancer
http://www.webone.com.au/~maxwell/ciss/documents/chemo2.html |
altman23
|
The FDA and Radiology
Discussion of how FDA bureaucracy has slowed development of new medical devices
http://www.rsna.org/REG/research/officeresdev/fda_rad/introduction.html |
altman23
|
The Goal of Chemotherapy: Little Agreement Between Patients and Their Doctors
ASCO 2001 Abstract 1542 Overall agreement on the goal of treatment was poor ([kappa]=.126, p=.07). When doctors identified the goal as palliation, 67% of patients thought that the goal of treatment was cure. However, in those cases where the doctors identified the goal as cure (20%), agreement with their patients was high (93%). When the doctor and patient agreed on the goal (45%), patients had higher expectations for success than their doctors - 80% vs 60% (p<.001). Twenty-three percent of patients did not know the likelihood of achieving the identified goal of the chemotherapy. Sixty percent of patients did not know how long they might live without chemotherapy, or how much longer they might live with chemotherapy
http://www.asco.org/ac/1,1003,_12-002326-00_18-002001-00_19-001542-00_29-00A,00.asp |
altman23
|
The Other Face of Cancer
The leit motif of the books is cancerrealism - an unblinking survey of cancer that provides a two-fold revelation; First, that cancer is not a medical problem to be understood, managed and ultimately solved by some noble-prize winners but a biological phenomenon, a time-bound universal process impartially affecting plants, insects, animals and us humans. Secondly, the genuine comprehension of cancer is a democratic process, for, of, and by the people irrespective of their layness or learnedness. Cancer-experts, or rather doctors, have a role to play - of providing ease if and when cancer causes disease.
http://www.healthlibrary.com/reading/cancer/index.htm |
altman23
|
The Role of Chemotherapy in the Treatment of Colon Cancer
Transcript of discussion with oncologists. Limited effects of chemo following resection in stage II patients. Some stage IV patients are curable if their metastases are resectable or can be converted to resectability with chemo.
http://www.healthology.com/webcast_transcript.asp?f=colon_cancer&c=colon_chemorole&spg=FIP |
altman23
|
The Thirty Years War
Jerome Groopman is an oncologist at Harvard University who writes for the New Yorker magazine. This article gives an overview of cancer research and reveals aspects of cancer trials not discussed by most oncologists
http://www.jeromegroopman.com/30yr.html |
altman23
|
Treating Colon Cancer With Chemotherapy: What's New?
Transcript of interview with oncologists Michael Lieberman and John McDonald. Discusses "neoadjuvant" (pre-surgical) use and other roles of chemo
http://www.healthology.com/webcast_transcript.asp?f=colon_cancer&c=colon_chemoforcancer&spg=FIP |
altman23
|
